Those exosomes showed better clinical outcomes compared to preexisting TNF-α or IL6 biologic inhibitors in mouse models of sepsis, experimental autoimmune encephalomyelitis and inflammatory bowel disease.41 The gene discussed is TNF; the disease is Sepsis.